Literature DB >> 16927447

A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia).

Diane L McKay1, Jeffrey B Blumberg.   

Abstract

Rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia) are popular tisanes in their native South Africa and have a growing worldwide market. Both herbal teas are used traditionally for medicinal purposes and are rich in polyphenols with rooibos a rare source of the dietary dihydrochalcones, aspalathin and nothofagin. The principal polyphenols in honeybush include the xanthone mangiferin and the flavonones hesperitin and isokuranetin. Despite their divergent phytochemical and nutrient compositions, rooibos and honeybush share potent antioxidant and antimutagenic activities in vitro. Animal model studies indicate both herbal teas possess potent antioxidant, immune-modulating and chemopreventive actions. However, human studies of rooibos are limited and of honeybush are absent. No adverse effects of rooibos or honeybush consumption as tisanes have been reported.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16927447     DOI: 10.1002/ptr.1992

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  26 in total

1.  Possible hepatotoxic effect of rooibos tea: a case report.

Authors:  Marjatta Sinisalo; Anna-Liisa Enkovaara; Kari T Kivistö
Journal:  Eur J Clin Pharmacol       Date:  2010-04       Impact factor: 2.953

2.  Ambient Profiling of Phenolic Content in Tea Infusions by Matrix-Assisted Ionization in Vacuum.

Authors:  Robert B Cody
Journal:  J Am Soc Mass Spectrom       Date:  2018-05-29       Impact factor: 3.109

3.  Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) inhibits high glucose-induced inflammation in vitro and in vivo.

Authors:  Sae-Kwang Ku; Soyoung Kwak; Yaesol Kim; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

4.  A CRITICAL STUDY ON THE INTERACTIONS OF HESPERITIN WITH HUMAN HEMOGLOBIN: FLUORESCENCE SPECTROSCOPIC AND MOLECULAR MODELING APPROACH.

Authors:  Sandipan Chakraborty; Sudip Chaudhuri; Biswapathik Pahari; Jasmine Taylor; Pradeep K Sengupta; Bidisha Sengupta
Journal:  J Lumin       Date:  2012-06       Impact factor: 3.599

5.  Anti-inflammatory Effects of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) In Vitro and In Vivo.

Authors:  Wonhwa Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 6.  Anti-ovarian cancer potential of phytocompound and extract from South African medicinal plants and their role in the development of chemotherapeutic agents.

Authors:  Chella Perumal Palanisamy; Bo Cui; Hongxia Zhang; Mani Panagal; Sivagurunathan Paramasivam; Uma Chinnaiyan; Selvaraj Jeyaraman; Karthigeyan Murugesan; Mauricio Rostagno; Vijayakumar Sekar; Srinivasa Prabhu Natarajan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

7.  Ethnobotanical survey of cooling herbal drinks from southern China.

Authors:  Yujing Liu; Selena Ahmed; Chunlin Long
Journal:  J Ethnobiol Ethnomed       Date:  2013-12-19       Impact factor: 2.733

8.  Antioxidant and astroprotective effects of a Pulicaria incisa infusion.

Authors:  Anat Elmann; Alona Telerman; Sharon Mordechay; Hilla Erlank; Rivka Ofir
Journal:  Oxid Med Cell Longev       Date:  2012-12-23       Impact factor: 6.543

9.  The Ayurvedic Medicine Salacia oblonga Attenuates Diabetic Renal Fibrosis in Rats: Suppression of Angiotensin II/AT1 Signaling.

Authors:  Lan He; Yanfei Qi; Xianglu Rong; Jianmin Jiang; Qinglin Yang; Johji Yamahara; Michael Murray; Yuhao Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

10.  Effects of consumption of rooibos (Aspalathus linearis) and a rooibos-derived commercial supplement on hepatic tissue injury by tert-butyl hydroperoxide in Wistar rats.

Authors:  B D Canda; O O Oguntibeju; J L Marnewick
Journal:  Oxid Med Cell Longev       Date:  2014-03-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.